Related Experiment Video
Updated: Jun 23, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
Published on: March 1, 2024
Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline
Koichiro Komai1, Kazuko Shiozawa, Yasushi Tanaka
1Division of Rheumatology, Department of Medicine and Biophysics, Kobe University Graduate School of Medicine and Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan.
Abstract:
Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by sicca symptoms, including dry eyes and dry mouth. Cevimeline is used for the treatment of dry mouth in patients with SS. Here we prospectively tested the clinical effectiveness of cevimeline at increasing saliva secretion in patients with SS, and the results were compared with the clinical parameters of the patients. Saliva secretion was increased >160% in 17 of 30 (56.7%) patients (P < 0.005). When the clinical parameters were compared between the patients who responded to cevimeline treatment and those who did not respond to the treatment, the frequency of patients presenting with hypergammaglobulinemia was significantly higher in the nonresponder group (P < 0.05). It thus appears that cevimeline is effective in SS patients with milder disease activity.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Hypersensitivity Reactions: Immune-Complex Reactions
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Cytomegalovirus Disease